NCT05316181 2026-02-12
KOV-HIPEC-02R
National Cancer Center, Korea
Phase 3 Active not recruiting
Clinical Trials
23 trialsNCT01279135 2026-02-06
PARCER
Tata Memorial Hospital
Phase 3 Completed
NCT06476639 2025-11-28
ANVU
Queensland Centre for Gynaecological Cancer
Phase 3 Not yet recruiting
NCT07068464 2025-07-16
ICRA
NHS Grampian
Phase 3 Not yet recruiting
NCT02446652 2025-05-29
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
Phase 3 Withdrawn
NCT06156514 2025-05-28
MICHELE
National Institute of Cancerología
Phase 3 Recruiting
NCT02859038 2025-02-10
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
Shanghai Gynecologic Oncology Group
Phase 3 Active not recruiting
NCT06542549 2024-08-07
Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer
Anhui Provincial Hospital
Phase 3 Not yet recruiting
NCT06539091 2024-08-06
Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer
Anhui Provincial Hospital
Phase 3 Not yet recruiting
NCT01611766 2021-06-10
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
Shanghai Gynecologic Oncology Group
Phase 3 Unknown
NCT04515602 2020-08-27
Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)
Shanghai Gynecologic Oncology Group
Phase 3 Not yet recruiting
NCT00096408 2019-03-20
Laparoscopic Approach to Cancer of the Endometrium
Queensland Centre for Gynaecological Cancer
Phase 3 Completed
NCT03162276 2018-09-07
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Sheba Medical Center
Phase 3 Unknown
NCT02957266 2016-11-15
CERVIPIB
The National Center of Oncology, Azerbaijan
Phase 3 Unknown
NCT00532194 2015-09-23
ICON6
Medical Research Council
Phase 3 Unknown
NCT00193830 2015-05-06
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
Tata Memorial Hospital
Phase 3 Completed
NCT02083211 2015-04-14
Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma
National Institute of Cancerología
Phase 3 Completed
NCT00850772 2014-06-12
OPEN
Queensland Centre for Gynaecological Cancer
Phase 3 Completed
NCT01654146 2012-07-31
ICON8
Medical Research Council
Phase 3 Unknown
NCT01288599 2012-07-03
Single Versus Conventional Laparoscopy for Benign Adnexal Disease
Sorlandet Hospital HF
Phase 3 Completed
NCT00122746 2011-10-13
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
International Atomic Energy Agency
Phase 3 Unknown
NCT00532818 2009-03-30
Hydralazine Valproate for Cervical Cancer
National Institute of Cancerología
Phase 3 Unknown
NCT00533299 2007-09-21
Hydralazine Valproate for Ovarian Cancer
National Institute of Cancerología
Phase 3 Unknown